Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill

Clinical trial NCT01073800 · COMPLETED

Trial details

NCT number: NCT01073800
Sponsor: University of Alberta
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myocardial Infarction Stroke Renal Failure

Start date: 2009-04-01
Primary completion: 2009-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.